Rama Phosphates (RAMAPHO)₹112.21+1.15%Fertilizers
In the Jun 2026 quarter (standalone), Rama Phosphates reported sales of ₹226 Cr, up 18.4% from Jun 2025, and net profit of ₹17.01 Cr, up 6.2% year on year. For the year to Mar 2026, sales were ₹896 Cr and net profit ₹53.06 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 171 | 116 | 186 | 154 | 210 | 181 | 202 | 191 | 247 | 239 | 220 | 226 |
| Expenses | 167 | 150 | 186 | 148 | 199 | 170 | 185 | 165 | 220 | 215 | 210 | 197 |
| Operating Profit | 6.01 | −32.05 | 0.00 | 6.01 | 11.02 | 10.03 | 17.05 | 27.07 | 27.06 | 24.07 | 10.02 | 28.06 |
| OPM % | 3.3% | −27.9% | 0.1% | 3.8% | 5.0% | 6.0% | 9.0% | 14.1% | 11.1% | 10.1% | 4.6% | 12.1% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 |
| Interest | 2.99 | 2.99 | 3.99 | 2.99 | 2.99 | 2.99 | 3.99 | 3.99 | 1.99 | 2.99 | 1.99 | 3.99 |
| Depreciation | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Profit before tax | 1.01 | −38.04 | −5.01 | 2.01 | 5.01 | 5.01 | 14.02 | 21.04 | 23.03 | 19.03 | 7.02 | 23.03 |
| Tax % | 7.0% | −21.0% | −53.0% | −4.0% | 43.0% | 28.0% | 61.0% | 25.0% | 24.1% | 27.0% | 22.0% | 25.0% |
| Net Profit | 1.01 | −30.01 | −2.01 | 2.01 | 3.01 | 4.01 | 5.01 | 16.02 | 17.03 | 14.01 | 5.01 | 17.01 |
| EPS (Rs) | 0.18 | −8.39 | −0.67 | 0.46 | 0.86 | 1.04 | 1.49 | 4.54 | 4.87 | 3.97 | 1.51 | 4.81 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 390 | 383 | 376 | 609 | 450 | 582 | 880 | 877 | 604 | 746 | 896 | 931 |
| Expenses | 365 | 362 | 357 | 568 | 426 | 519 | 769 | 804 | 626 | 700 | 808 | 842 |
| Operating Profit | 25.03 | 21.04 | 19.03 | 40.09 | 24.06 | 63.16 | 112 | 73.17 | −21.04 | 46.13 | 88.19 | 89.21 |
| OPM % | 6.0% | 6.0% | 5.0% | 7.0% | 5.0% | 11.0% | 13.0% | 8.1% | −3.6% | 6.0% | 10.0% | 9.6% |
| Other Income | 1.01 | 4.01 | 1.01 | 1.01 | 5.01 | 1.01 | 4.01 | 1.01 | 2.01 | 2.01 | 1.01 | 2.02 |
| Interest | 10.98 | 8.99 | 7.99 | 7.99 | 2.99 | 1.99 | 10.98 | 8.98 | 12.97 | 12.98 | 10.99 | 10.96 |
| Depreciation | 3.98 | 2.99 | 2.99 | 2.99 | 3.99 | 4.98 | 10.96 | 9.96 | 8.96 | 7.98 | 7.97 | 7.96 |
| Profit before tax | 12.02 | 13.02 | 8.01 | 31.03 | 22.04 | 57.13 | 94.22 | 55.09 | −41.05 | 26.04 | 70.17 | 72.11 |
| Tax % | 32.0% | 32.0% | 34.1% | 36.1% | 19.0% | 26.1% | 25.0% | 25.0% | −25.0% | 46.0% | 25.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 8.01 | 8.01 | 5.01 | 19.01 | 18.02 | 42.05 | 70.05 | 41.05 | −31.01 | 14.02 | 53.06 | 53.06 |
| EPS (Rs) | 2.29 | 2.39 | 1.53 | 5.49 | 4.98 | 11.89 | 19.80 | 11.55 | −8.79 | 3.88 | 14.89 | 15.16 |
| Dividend payout % | 18.0% | 21.1% | 33.0% | 9.0% | 10.0% | 8.0% | 5.0% | 4.0% | 0.0% | 6.0% | 2.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17.97 | 17.97 | 17.97 | 17.96 | 17.96 | 17.98 | 17.97 | 17.95 | 17.95 | 17.95 | 17.95 | 17.96 |
| Reserves | 98.32 | 104 | 113 | 116 | 134 | 149 | 187 | 252 | 291 | 335 | 355 | 406 |
| Borrowings | 58.08 | 54.07 | 51.06 | 47.06 | 27.04 | 24.03 | 6.01 | 58.96 | 118 | 149 | 126 | 139 |
| Other Liabilities | 105 | 114 | 119 | 97.53 | 114 | 108 | 101 | 113 | 107 | 124 | 136 | 157 |
| Total Liabilities | 279 | 291 | 301 | 279 | 292 | 299 | 311 | 443 | 534 | 625 | 634 | 719 |
| Fixed Assets | 31.91 | 33.93 | 31.93 | 30.92 | 32.93 | 42.87 | 71.81 | 78.76 | 76.84 | 167 | 164 | 159 |
| CWIP | 5.98 | 3.98 | 3.99 | 4.98 | 12.94 | 19.93 | 4.98 | 13.94 | 19.91 | 22.91 | 24.91 | 47.78 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 241 | 253 | 265 | 243 | 247 | 236 | 234 | 349 | 438 | 435 | 444 | 512 |
| Inventories | 93.76 | 53.91 | 64.81 | 84.76 | 97.78 | 107 | 117 | 177 | 176 | 215 | 209 | 214 |
| Trade receivables | 54.97 | 78.01 | 73.95 | 56.02 | 56.96 | 47.99 | 37.99 | 20.99 | 63.02 | 74.93 | 60.02 | 72.01 |
| Cash & equivalents | 4.02 | 5.02 | 4.01 | 5.02 | 5.02 | 6.02 | 8.03 | 6.02 | 6.02 | 10.03 | 12.05 | 12.04 |
| Total Assets | 279 | 291 | 301 | 279 | 292 | 299 | 311 | 443 | 534 | 625 | 634 | 719 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 7.03 | 18.07 | 12.04 | 13.05 | 21.08 | 26.10 | 44.14 | −9.03 | −36.10 | −5.02 | 40.14 | 20.06 |
| Cash from investing activity | −3.01 | −2.01 | −3.01 | −2.01 | −12.05 | −21.09 | −21.07 | −32.11 | −8.03 | −12.05 | −4.01 | −22.08 |
| Cash from financing activity | −5.02 | −14.04 | −10.02 | −10.02 | −9.02 | −5.01 | −23.05 | 40.11 | 45.08 | 16.03 | −36.08 | 1.01 |
| Net cash flow | −2.01 | 1.01 | −1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 3.93 | 3.30 | 2.10 | 3.21 | 12.16 | 21.11 | 18.94 | 34.26 | 10.17 | 8.04 | 7.43 | 24.50 |
| Free cash flow | 3.01 | 14.99 | 9.99 | 9.99 | 7.99 | 5.01 | 24.97 | −42.95 | −45.94 | −13.01 | 31.97 | −3.99 |
| CFO / OP % | −706.9% | 72.1% | 76.1% | 88.1% | 73.1% | 135.0% | 88.0% | 13.1% | −24.9% | 15.0% | 99.1% | 31.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 50 | 72 | 70 | 54 | 33 | 38 | 23 | 8 | 25 | 44 | 29 | 28 |
| Inventory days | 118 | 72 | 97 | 128 | 82 | 132 | 111 | 116 | 103 | 167 | 150 | 132 |
| Days payable | 108 | 117 | 139 | 114 | 70 | 106 | 71 | 41 | 48 | 75 | 74 | 69 |
| Cash conversion cycle | 62 | 29 | 31 | 70 | 48 | 66 | 66 | 85 | 82 | 138 | 107 | 93 |
| Working capital days | 64 | 74 | 87 | 93 | 61 | 80 | 76 | 68 | 85 | 95 | 87 | 90 |
| ROCE % | −2.0% | 13.0% | 12.0% | 9.0% | 21.0% | 12.0% | 29.0% | 39.0% | 17.0% | −6.0% | 8.0% | 15.0% |
For the Jun 2026 quarter, Rama Phosphates reported sales of ₹226 Cr, up 18.4% year on year and net profit of ₹17.01 Cr, up 6.2% year on year. The operating margin was 12.1%.
Rama Phosphates' sales for the year to Mar 2026 were ₹896 Cr; over the last twelve months they were ₹931 Cr.
Net profit for the year to Mar 2026 was ₹53.06 Cr, and ₹53.06 Cr over the last twelve months. Earnings per share over the same trailing period were ₹15.16.
Rama Phosphates reported borrowings of ₹139 Cr at Mar 2026, against cash and equivalents of ₹12.04 Cr.
Cash from operations was ₹20.06 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹3.99 Cr.